Pathophysiology of Atherosclerotic Plaque Development and Rupture: An Overview

Seminars in Vascular Medicine

Volumn 3, Issue 4, 2003, Pages 347-354

  Rohde, Luis E P ^b   Lee, Richard T ^a,c  

^a Partners Research Facility   (United States)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Atherosclerosis; Inflammation; Plaque rupture; Unstable atheroma

Indexed keywords

C REACTIVE PROTEIN; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BIOCHEMISTRY; BLOOD VESSEL RUPTURE; CLINICAL FEATURE; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; MECHANICS; MORPHOLOGY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SYMPTOM; THROMBOGENESIS; THROMBOSIS;

ARTERIOSCLEROSIS; CORONARY THROMBOSIS; EXTRACELLULAR MATRIX; HUMANS; INFLAMMATION; RUPTURE, SPONTANEOUS;

EID: 1642453577     PISSN: 15289648     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-815692     Document Type: Review

References (66)

1. Libby P. Molecular bases of acute coronary syndromes. Circulation 1995;91:2844-2850
2. Shah PK. New insights into the pathogenesis and prevention of acute coronary syndromes. Am J Cardiol 1997;79:17-23
3. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-126
4. Davies MJ, Gordon JL, Pigott R, Woolf N, Katz D, Kyriakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993;171:223-229
5. O'Brien KD, Allen MD, McDonald TO, et al. Vascular cell endothelial molecule-1 is expressed in human coronary atherosclerotic plaques. J Clin Invest 1993;92:945-951
6. Li H, Cybulsky MI, Gimbrone MA Jr, Libby P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 1993;13:197-204
7. Nageh MF, Sandberg ET, Marotti KR, et al. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscler Thromb Vasc Biol 1997;17:1517-1520
8. Johnson RC, Chapman SM, Dong ZM, et al. Absence of P-selectin delays fatty streak formation in mice. J Clin Invest 1997;99:1037-1043
9. Peter K, Nawroth P, Conradt C, et al. Circulating vascular adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol 1997;17:505-512
10. Rohde LE, Lee RT, Rivero J, et al. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol 1998;18:1765-1770
11. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-1143
12. Rohde LE, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol 1999;84:1018-1022
13. Rohde LE, Hennekens CH, Ridker PM. A cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men. Arterioscler Thromb Vasc Biol 1999;19:1595-1599
14. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW, for the European Concerted Action on Thrombosis, and Disabilities Angina Pectoris Study Group. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332:635-641
15. Harverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MG. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action in Thrombolysis and Disabilities Angina Pectoris Study Group. Lancet 1997;349:462-466
16. Kuller LH, Tracy RP, Shaten J, Meinhahn EN, for the MRFIT Research Group. Relation of C-reactive protein and coronary artery disease in the MRFIT nested case-control study. Am J Epidemiol 1996;144:537-547
17. Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997;17:1121-1127
18. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and risks of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979
19. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-733
20. Ridker PM, Rifai N, Pfeffer MA, et al, for the Cholesterol and Recurrent Events (CARE) Investigators. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation 1998;98:839-844
21. Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001;344:1959-1965
22. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-436
23. Kol A, Sukhova GK, Lichtman AH, et al. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage TNF-α and matrix metalloproteinase expression. Circulation 1998;98:300-307
24. Danesh J, Whincup P, Walker M, et al. Chlamydia pneumoniae 1gG titres and coronary heart disease: prospective study and meta-analysis. BMJ 2000;321:208-213
25. Lee RT, Schoen FJ. Pathology of unstable coronary plaque. In: Rutherford JD, ed. Unstable Angina. New York: Marcel Dekker; 1991:1-25
26. Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996;93:1354-1363
27. Born GVR, Richardson PD. Mechanical properties of human atherosclerosis. In: Glagov S, Newman W, Schaffer S, eds. Pathobiology of the Human Atherosclerotic Plaques. New York: Springer-Verlag; 1990:413-424
28. Davies MJ, Thomas AC. Plaque fissuring-the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985;53:363-373
29. Richardson PD, Davies MJ, Born GVR. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989;2:941-944
30. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol 1997;17:1859-1867
31. Libby P, Lee RT. Role of activated macrophages and T-lymphocytes in rupture of coronary plaques. In: Braumwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. Update. Vol. 2. Philadelphia: WB Saunders; 1995:1-9
32. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 1991;11:1223-1230
33. Geng Y-J, Henderson L, Levesque E, et al. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1997;17:2200-2208
34. Nikkari ST, O'Brien KD, Ferguson M, et al. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 1995;92:1393-1398
35. Dellery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res 1995;77:863-868
36. Galis ZS, Muszynski M, Sukhova GK, et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 1994;75:181-189
37. Lee E, Grodzinsky AJ, Libby P, Clinton SK, Lark MW, Lee RT. Human vascular smooth muscle cell-monocyte interactions and metalloproteinase secretion in culture. Arterioscler Thromb Vasc Biol 1995;15:2283-2289
38. Galis ZS, Sukhova G, Kranzhofer R, Clark S, Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 1995;92:402-406
39. Shah PK, Falk E, Badimon JJ, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: potential role of matrix-degrading metalloproteinases and implications of plaque rupture. Circulation 1995;92:1565-1569
40. Lendon CL, Davies MJ, Born GVR, Richardson PD. Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis 1991;87:87-90
41. Lee RT, Grodzinsky AJ, Franf EH, Kamm RD, Schoen FJ. Structure dependent dynamic mechanical behavior of fibrous caps from human atherosclerotic plaque. Circulation 1991;83:1764-1770
42. Loree HM, Grodzinsky AJ, Park SY, Gibson LJ, Lee RT. Static circumferential modulus of human atherosclerotic tissue. J Biomech 1994;27:195-204
43. Loree HM, Tobias BJ, Gibson LJ, Kamm RD, Small DM, Lee RT. Mechanical properties of model atherosclerotic lesion lipid pools. Arterioscler Thromb 1994;14:230-234
44. Rohde LE, Lee RT. Mechanical stress and strain and the vulnerable atherosclerotic lesion. In: Fuster V, ed. The Vulnerable Atherosclerotic Plaque: Understanding, Identification and Modification. Armonk, NY: Futura Publishing; 1999:305-316
45. Loree HM, Kamm RD, Stringfellow RG, Lee RT. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res 1992;71:850-858
46. Cheng GC, Loree HM, Kamm RD, Fishbein MC, Lee RT. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation. Circulation 1993;87:1179-1187
47. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001;104:365-372
48. Bogaty P, Hackett D, Davies G, Maseri A. Vasoreactivity of the culprit lesion in unstable angina. Circulation 1994;90:5-11
49. Bevilacqua MP, Schleef R, Gimbrone MAJ, et al. Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. J Clin Invest 1986;78:587-591
50. Mach F, Schonbeck U, Bonnefoy J-Y, Pober JS, Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 1997;96:396-399
51. Mach F, Schönbeck U, Sukhova GK, Atkinson E, Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signaling. Nature 1998;394:200-203
52. Marx N, Sukhova GK, Collins T, et al. PPAR-α activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation 1999;99:3125-3131
53. Marx N, Mackman N, Schoenbeck U, et al. PPAR-α activators inhibit tissue factor expression and activity in human monocytes. Circulation 2001;103:213-219
54. Kato H. Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects. Arterioscler Thromb Vasc Biol 2002;22:539-548
55. Yin X, Yutani C, Ikeda Y, et al. Tissue factor pathway inhibitor gene delivery using HVJ-AVE liposomes markedly reduces restenosis in atherosclerotic arteries. Cardiovasc Res 2002;56:454-463
56. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfen M, O'Neill WW. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000;343:915-922
57. Asakura M, Ueda Y, Yamaguchi O, et al. Extensive development of Vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. J Am Coll Cardiol 2001;37:1284-1288
58. Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 2002;106:804-808
59. Spagnoli LG, Bonanno E, Mauriello A, et al. Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. J Am Coll Cardiol 2002;40:1579-1588
60. Buffon A, Biasucci LM, Liuzzo G, D'onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 2002;347:5-12
61. Lee RT, Loree HM, Cheng GC, Lieberman EH, Jaramillo N, Schoen FJ. Computational structural analysis based on intravascular ultrasound imaging before in vitro angioplasty: prediction of plaque fracture locations. J Am Coll Cardiol 1993;21:777-782
62. Hatsukami TS, Ross R, Polissar NL, Yuan C. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 2000;102:959-964
63. Yuan C, Mitsumori LM, Ferguson MS, et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 2001;104:2051-2056
64. Nair A, Kuban BD, Tuzcu M, Schoenhagen P, Nissen SE, Vince DG. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 2002;106:2200-2206
65. Stefanidis C, Diamantopoulos L, Vlachopoulos C, et al. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo. A new method of detection by application of a special thermography catheter. Circulation 1999;99:1965-1971
66. Stefanidis C, Toutouzaz K, Tsiamis E, et al. Increased local temperature in human coronary atherosclerotic plaques: an independent predictor of clinical outcome in patients undergoing a percutaneous coronary intervention. J Am Coll Cardiol 2001;37:1277-1283